1. Home
  2. PDFS vs ADMA Comparison

PDFS vs ADMA Comparison

Compare PDFS & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDF Solutions Inc.

PDFS

PDF Solutions Inc.

HOLD

Current Price

$55.92

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$9.15

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDFS
ADMA
Founded
1992
2004
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.9B
IPO Year
2000
2012

Fundamental Metrics

Financial Performance
Metric
PDFS
ADMA
Price
$55.92
$9.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$39.67
$25.67
AVG Volume (30 Days)
812.0K
3.6M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.12
0.19
Revenue
N/A
$42,219,783.00
Revenue This Year
$22.13
$27.46
Revenue Next Year
$18.92
$22.11
P/E Ratio
$466.08
$48.79
Revenue Growth
N/A
43.85
52 Week Low
$18.19
$7.21
52 Week High
$71.69
$20.46

Technical Indicators

Market Signals
Indicator
PDFS
ADMA
Relative Strength Index (RSI) 46.99 59.64
Support Level $27.68 $7.38
Resistance Level $56.46 $11.42
Average True Range (ATR) 4.21 0.32
MACD -1.80 0.10
Stochastic Oscillator 26.83 84.09

Price Performance

Historical Comparison
PDFS
ADMA

About PDFS PDF Solutions Inc.

PDF Solutions Inc provides products and services designed to empower organizations across the semiconductor and electronics ecosystem to connect, collect, manage, and analyze data about design, equipment, manufacturing, and test to improve the yield and quality of their products and operational efficiency. The Company's products, services, and solutions include proprietary software, physical intellectual property (IP) for integrated circuit (IC) designs, electrical measurement hardware tools, methodologies, and professional services.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: